125 citations for Su's paper talking about the impressive FTO inhibitor, CS1 and CS2, but how many of those citing the paper realise that CS1 is bisantrene / Zantrene and is easily available for them to do academic research on?
How many other academic FTO researchers know that CS1 is bisantrene /Zantrene when they are casting around looking for a powerful FTO inhibitor to test their FTO hypotheses on?
presumably, RAC wants lots and lots of academics to use Zantrene to test their ideas of the role over-expression of FTO plays in various diseases.
what a shame these key researchers don't know that a powerful FTO inhibitor exists. I wonder how to tell them about Zantrene?
what if Race Oncology created a useful educational package to send leading FTO researchers who may not have realised that there is an easy way to test their FTO inhibition ideas?
125 citations for Su's paper talking about the impressive FTO...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.035(2.18%) |
Mkt cap ! $266.3M | |||
| Open | High | Low | Value | Volume |
| $1.59 | $1.62 | $1.56 | $101.6K | 64.09K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7451 | $1.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.60 | 408 | 1 |
View Market Depth
| Last trade - 15.53pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.58 |
Change
-0.035 ( 1.25 %) |
||||
| Open | High | Low | Volume | ||
| $1.58 | $1.62 | $1.56 | 7255 | ||
| Last updated 15.57pm 05/06/2024 ? | |||||
| RAC (ASX) Chart |